We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Project Set to Develop Algorithm Able to Accurately Predict and Detect Sepsis

By LabMedica International staff writers
Posted on 18 Nov 2019
Print article
Image: The DxH 900 hematology analyzer (Photo courtesy of Beckman Coulter)
Image: The DxH 900 hematology analyzer (Photo courtesy of Beckman Coulter)
A large research contract has been signed that will enable the development and commercialization of a novel machine-learning-based sepsis detection algorithm.

Sepsis is caused by an inflammatory immune response triggered by an infection. It is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. Common signs and symptoms include fever, increased heart rate, increased breathing rate, and confusion. There may also be symptoms related to a specific infection, such as a cough with pneumonia, or painful urination with a kidney infection. In the very young, old, and people with a weakened immune system, there may be no symptoms of a specific infection and the body temperature may be low or normal, rather than high.

The 1.25 million USD contract (with potential expansion to an additional 6.5 million USD) from the [U.S.] Biomedical Advanced Research and Development Authority (BARDA) provides funds for Beckman Coulter, Inc. (Brea, CA, USA) in collaboration with Dascena, Inc. (Oakland, CA, USA) to develop and commercialize a novel machine-learning-based sepsis detection algorithm. BARDA is a U.S. Department of Health and Human Services office responsible for procurement and development of countermeasures principally against bioterrorism, but also including chemical, nuclear, and radiological threats as well as pandemic influenza and emerging diseases. More broadly if functions as an interface between the U.S. Government and the biomedical industry.

By combining novel laboratory test parameter values with electronic health record information, the objective of this project is the development of a next-generation analytic algorithm able to accurately predict and detect sepsis earlier. The project is set to integrate the novel laboratory parameters generated by the Beckman Coulter DxH 900 hematology analyzer into Dascena’s best-in-class sepsis prediction and detection algorithm.

The Beckman Coulter FDA-cleared Early Sepsis Indicator kit used with the DxH 900 Hematology Analyzer has already been shown to improve diagnosis of sepsis by 43% and, together with clinical signs and symptoms, to improve the ability to rule out sepsis by 63%. The Early Sepsis Indicator measures monocyte distribution width to support prompt clinical decision making. The next-generation analytic algorithm being developed by Dascena will be able to accurately predict and detect sepsis even earlier.

“Sepsis, defined as dysregulated immune response to infection, is a high-priority health concern accounting for the deaths of approximately 250,000 Americans and millions globally each year, and is the most expensive medical condition encountered in most hospitals,” said Dr. Elliott Crouser, professor of pulmonary, critical care, and sleep medicine at the Ohio State University Wexner Medical Center (Columbus, OH, USA), and principal investigator in the clinical trial for Beckman Coulter’s Early Sepsis Indicator. “Delays in the detection and treatment of sepsis during its early phases can contribute significantly to adverse outcomes. The objective of this project will be to deliver earlier and more accurate sepsis detection. The resulting predictive analytic algorithm for sepsis detection is expected to have a major global impact.”

Related Links:
Beckman Coulter, Inc.
Dascena, Inc.
Ohio State University Wexner Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.